BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Celyad Oncology reports third quarter 2023 financial results and recent business highlights

  Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor T-cell therapies, reports its financial results for the third quarter of 2023 and provides an update on recent business developments.

  November 9, 2023

   · 

  9 min read
• Angle PLC Announces Trading and Business Update

  ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumour cell diagnostic solutions for use in research, drug development and clinical oncology, is providing a trading and business update.

  November 9, 2023

   · 

  5 min read
• Business

  Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights

  Shattuck Labs, Inc. reported financial results for the quarter ended September 30, 2023, and provided recent business highlights.

  November 9, 2023

   · 

  15 min read
• BioForest

  NanoString to Webcast Presentations from Upcoming November 2023 Healthcare Conferences

  NanoString Technologies, Inc. announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.

  November 9, 2023

   · 

  2 min read
• Business

  Aveanna Healthcare Holdings Announces Third Quarter 2023 Financial Results

  Aveanna Healthcare Holdings Inc. announced financial results for the three and nine-month periods ended September 30, 2023.

  November 9, 2023

   · 

  33 min read
• Business

  Ocugen Provides Business Update with Third Quarter 2023 Financial Results

  Ocugen, Inc. reported third quarter 2023 financial results along with a general business update.

  November 9, 2023

   · 

  9 min read
• Oncolytics Provides Update on Pancreatic Cancer Program for Pelareorep

  Oncolytics Biotech® Inc., a clinical-stage immunotherapeutics company focused on oncology, provided an update on the planned program for pelareorep in pancreatic ductal adenocarcinoma.

  November 9, 2023

   · 

  6 min read
• Stevanato Group to Present at the 2023 Jefferies London Healthcare Conference

  Stevanato Group S.p.A. announced that it will participate in the Jefferies London Healthcare Conference taking place from November 14, 2023 to November 16, 2023.

  November 9, 2023

   · 

  1 min read
• Business

  BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

  BD, a leading global medical technology company, announced results for its fourth quarter and full year of fiscal 2023, which ended September 30, 2023.

  November 9, 2023

   · 

  20 min read
• Business

  Trevena to Release Third Quarter 2023 Financial Results on November 14, 2023

  Trevena, Inc. announced that it will release its financial results for the third quarter ended September 30, 2023, prior to the market open on Tuesday, November 14, 2023.

  November 9, 2023

   · 

  2 min read